AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novonesis AS

Director's Dealing Jan 29, 2024

3377_rpt_2024-01-29_195cdf2e-e84e-432e-8046-d4edba952dbe.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Trading by management and close relations of management

January 29, 2024 Company announcement No. 04

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Novo Holdings A/S
2. Reason for the notification
a) Position/status Novo Holdings A/S is closely related to its CEO Kasim Kutay,
who is a member of Novozymes A/S' board of directors.
b) Initial notification/
Amendment
Initial notification
3. auction monitor Details of the issuer, emission allowance market participant, auction platform, auctioneer or
a) Name Novozymes A/S
b) LEI 529900T6WNZXD2R3JW38
4. conducted Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each
type of transaction; (iii) each date; and (iv) each place where transactions have been
a) Description of the financial
instrument, type of instrument
B-Shares
Identification code DK0060336014
b) Nature of the transaction Exchange of shares in Novozymes A/S in connection with merger
between Novozymes A/S and Chr. Hansen Holding A/S
c) Price(s) and volume(s) Price(s)
28,983,112 shares in Chr.
Hansen Holding A/S
Volume(s)
29,641,028 shares
d) Aggregated information
-
Aggregated volume
-
Price
e) Date of transaction 29 January 2024
f) Place of the transaction Outside a trading venue

About Novozymes

Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com

Novozymes A/S

Krogshoejvej 36 2880 Bagsvaerd Denmark

Phone: +45 4446 0000

Trading by management and close relations of management. Company announcement No. 04

Contact information
Investor Relations
Tobias Bjorklund +45 3077 8682 [email protected]
Anders Enevoldsen +45 5350 1453 [email protected]
Media Relations
Lina Danstrup +45 3077 0552 [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.